Nearly two-thirds of people with scleroderma undergo physical therapy — often called PT — and are generally satisfied…
Articles by Marta Figueiredo, PhD
Under-the-skin treatment with tiny vesicles produced by mesenchymal stem cells significantly lessened skin abnormalities and scarring, while reducing markers of…
Despite immunosuppressive therapy, skin and lung involvement still progresses in about 20% of people with early or at-risk diffuse…
A remote, peer-facilitated group intervention created to provide mental health and social support during the COVID-19 pandemic significantly eased…
Distinct profiles of gene activity in skin samples distinguish different disease stages in juvenile localized scleroderma, a study suggests.
CAN10, — Cantargia’s experimental therapy for scleroderma and myocarditis, or inflammation of the heart muscle — appears safe…
People with scleroderma have abnormal levels of several fatty molecules and their body’s ability to remove excess cholesterol is…
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
Three factors —  the presence of digital ulcers, Raynaud’s phenomenon, and gastrointestinal (GI) symptoms — appear to predict a worsening…
The first wave of COVID-19Â in Europe severely disrupted access to care and raised stress and anxiety in people with…